
The Library
The role of hepcidin-25 in kidney transplantation
Tools
Chan, W., G. Ward, Douglas, McClean, Andrew, A. Bosch, Jos, Jones, David, Kaur, Okdeed, Drayson, Mark, Whitelegg, Alison, Iqbal, Tariq, McTernan, P. G. (Philip G.), Tselepis, Chris and Borrows, Richard (2013) The role of hepcidin-25 in kidney transplantation. Transplantation Journal, Volume 95 (Number 11). pp. 1390-1395. doi:10.1097/TP.0b013e31828d8489 ISSN 0041-1337.
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: http://dx.doi.org/10.1097/TP.0b013e31828d8489
Abstract
Background: Hepcidin-25 is a peptide hormone involved in iron absorption and homeostasis and found at increased serum levels in conditions involving systemic inflammation, renal dysfunction, and increased adiposity. Hepcidin may play a role in the pathogenesis of anemia, but its role in kidney transplantation is undefined. Methods: This study enrolled 100 stable patients beyond 12 months after transplantation, from a large single United Kingdom center. Serum hepcidin-25 level, and relevant demographic and laboratory data pertinent to posttransplantation anemia, were measured and collected. Independent predictors of serum hepcidin were evaluated, and the relationship between hepcidin and hemoglobin, assessed. Results: Independent associations were seen between higher hepcidin levels and allograft dysfunction (estimated glomerular filtration rate), increased inflammation (high-sensitivity C-reactive peptide), higher transferrin saturation (a marker of iron stores), and the use of marrow-suppressive medication (P<0.05 for all). Higher fat tissue index (whole-body multifrequency bioimpedance measurement) was also associated with higher hepcidin levels, but this relationship did not persist after adjustment for inflammation (high-sensitivity C-reactive peptide). In turn, inflammation was associated with increased fat tissue index (P=0.01) and male gender (P=0.04). A nonlinear association between serum hepcidin level and hemoglobin was seen, with a progressive fall in hemoglobin as hepcidin levels rose to 100 ng/mL, but little effect thereafter (P=0.009). This association was independent of renal dysfunction and female gender, both of which were also independently associated with a lower hemoglobin level. Conclusions: These results highlight possible mechanisms of hemoglobin reduction in kidney transplantation patients, and the therapeutic opportunities from understanding the role of hepcidin in this context.
Item Type: | Journal Article | ||||
---|---|---|---|---|---|
Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Biomedical Sciences > Translational & Experimental Medicine > Metabolic and Vascular Health (- until July 2016) Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School |
||||
Journal or Publication Title: | Transplantation Journal | ||||
Publisher: | Lippincott Williams & Wilkins | ||||
ISSN: | 0041-1337 | ||||
Official Date: | 15 June 2013 | ||||
Dates: |
|
||||
Volume: | Volume 95 | ||||
Number: | Number 11 | ||||
Page Range: | pp. 1390-1395 | ||||
DOI: | 10.1097/TP.0b013e31828d8489 | ||||
Status: | Peer Reviewed | ||||
Publication Status: | Published | ||||
Access rights to Published version: | Restricted or Subscription Access |
Request changes or add full text files to a record
Repository staff actions (login required)
![]() |
View Item |